IMV Stock Price, News & Analysis
Company Description
IMV (NASDAQ: IMV) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $9.8M.
IMV stock has declined 93.2% over the past year.
This page provides a comprehensive overview of IMV stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
IMV (IMV) stock. Over the past 12 months, the stock has lost 93.2%. At a market capitalization of $9.8M, IMV is classified as a micro-cap stock with approximately 11.7M shares outstanding.
Latest News
IMV has 10 recent news articles. Of the recent coverage, 3 articles coincided with positive price movement and 3 with negative movement. Key topics include earnings, management, conferences, clinical trial. View all IMV news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
IMV Company Profile & Sector Positioning
IMV (IMV) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing IMV often look at related companies in the same sector, including In8Bio, Inc. (INAB), Diffusion Pharmaceuticals Inc. (DFFN), Bolt Biotherapeutics, Inc. (BOLT), Matinas Biopharm (MTNB), and Transcode Therapeutics Inc (RNAZ). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate IMV's relative position within its industry.